Previously, Medicare only covered GLP-1 drugs prescribed for diabetes or related cardiovascular conditions, excluding most cases where obesity was the primary condition
Pharmaceutical GLP-1 receptor agonists, such as semaglutide, are widely used for managing type 2 diabetes and obesity
It also helps explain how GLP-1 microdosing is being explored during perimenopause and menopause, where hormonal shifts can influence dose tolerance and treatment experience
Finally, we removed comments shorter than 100 characters to reduce noise and enhance content depth
| Frequently asked questions | Take home message Mounjaro (tirzepatide) is significantly more effective than Trulicity (dulaglutide) for both weight loss and blood sugar control
Compounded semaglutide from a reputable pharmacy is made with a pharmaceutical-grade form of the active ingredient in Wegovy and Ozempic